Beta Cell therapie in diabetes Vrije Universiteit Brussel
Diabetes Pathologie & Therapie, Pathologie/moleculaire en cellulaire geneeskunde, Inwendige Geneeskundige Specialiteiten, Medische Biochemie, Pathologische Biochemie en Fysiologie
Type 1 diabetes is caused by a major loss in insulin-producing beta cells, which proceeds after diagnosis, often to complete depletion. The objective of our consortium is to develop and implement interventions for restoring the beta cell mass. Methods can differ with the stage of the disease but will require the same insights and address similar targets. In this FP7 program we investigated three tracks that can lead to beta cell replacement in ...